PAX9 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the PAX9 protein, which stands for paired box 9. PAX9 is a transcription factor that belongs to the paired box (PAX) family of proteins, which play critical roles in regulating gene expression during embryonic development. This protein is essential for the development of various tissues and organs, including the formation of teeth, where it regulates the expression of genes involved in the growth and differentiation of dental tissues. By binding to specific DNA sequences, PAX9 influences the transcriptional activity of target genes, thereby orchestrating complex developmental processes.
Structurally, PAX9 inhibitors can encompass a wide range of molecules, including small organic compounds, peptides, or larger biomolecules engineered to interact specifically with the DNA-binding domain or other functional regions of the PAX9 protein. These inhibitors typically function by blocking the ability of PAX9 to bind to its target DNA sequences, thereby preventing it from activating or repressing the transcription of its target genes. By inhibiting PAX9, these compounds can disrupt the regulatory networks controlled by this transcription factor, leading to alterations in the expression of genes critical for development. The study of PAX9 inhibitors is crucial for understanding the molecular mechanisms by which PAX9 regulates gene expression and the broader implications of its activity on developmental processes. Research into these inhibitors provides valuable insights into the role of transcription factors in cellular differentiation, tissue formation, and the maintenance of developmental programs. By exploring the effects of PAX9 inhibition, scientists can gain a deeper understanding of the intricate regulatory networks that govern development and the importance of precise gene regulation in maintaining proper tissue and organ formation.
関連項目
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
ノッチシグナル伝達経路を介してペアードボックス(PAX)の機能に影響を及ぼし、神経発生に影響を与える可能性がある、α-セクレターゼ阻害剤。 | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $182.00 $661.00 | 10 | |
DNA結合ドメインと相互作用することで、ペアードボックス(PAX)媒介転写活性化を阻害する可能性がある真菌代謝物。 | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
神経発生に関与するペアードボックス(PAX)の発現およびシグナル伝達経路に影響を及ぼす可能性があるスフィンゴシン-1-リン酸受容体モジュレーター。 | ||||||
UNC0631 | 1320288-19-4 | sc-397011 | 5 mg | $149.00 | ||
強力なG9aヒストンメチルトランスフェラーゼ阻害剤で、ペアードボックス(PAX)の発現のエピジェネティックな制御に影響を与える可能性がある。 | ||||||
Cryptotanshinone | 35825-57-1 | sc-280649 | 10 mg | $117.00 | 1 | |
神経発生に影響を与える可能性があり、ペアードボックス(PAX)の発現を阻害する可能性のある天然化合物。 | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
神経細胞におけるペアードボックス(PAX)の発現とエピジェネティックな制御に影響を与える可能性のあるDNAメチルトランスフェラーゼ阻害剤。 | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
直接的なペアボックス(PAX)阻害剤ではないが、イブルチニブはブルトン型チロシンキナーゼ(BTK)阻害剤であり、B細胞のシグナル伝達経路に影響を与える。これは間接的にペアボックス(PAX)活性に影響を与える。 | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
直接的なペアボックス(PAX)阻害剤ではないが、レナリドミドはB細胞の機能と生存に影響を与える可能性があり、ペアボックス(PAX)活性に影響を与える可能性がある。 |